Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00814450
Other study ID # ASNG-LFNA-101-IL
Secondary ID
Status Completed
Phase N/A
First received December 23, 2008
Last updated December 29, 2009
Start date December 2008
Est. completion date June 2009

Study information

Verified date December 2009
Source ActiViews Ltd.
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

This study is intended to provide clinical data regarding safety and accuracy of the ActiSight™ Needle Guidance System in assisting Chest CT guided biopsies.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 2009
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female subjects, 18 years of age or older at the time of enrollment

- Subjects meeting all medical conditions for percutaneous chest aspiration/biopsy with safe path to lesion between ribs, however, not in the breast area in women or men with gynecomastia

- Single target pulmonary lesion greater than 10 mm in size (diameter) and depth of lesion greater than 40 mm from the skin

- INR <1.3

- Written informed consent to participate in the study

- Ability to comply with the requirements of the study procedures

Exclusion Criteria:

- Fibrous tissue or cyst in access path (not including target lesion)

- Hemophilia, thrombocytopenia, coagulopathy, or other elevated risk for bleeding or abnormal clotting

- Central lesion is located in radius of less than 2 cm from lobar blood vessels and the heart.

- The selected needle path has a safety margin of less than 2 cm from major blood vessels and the heart

- Use of ticlopidine or similar antithrombotic medication

- For subjects taking warfarin or other anticoagulant medication, INR >1.3

- Pulmonary hypertension, heart failure, renal failure, or blood dyscrasia

- Subjects who cannot tolerate mild sedation

- Subjects with FEV1 < 800 mL unless approved by principal investigator following consultation with multidisciplinary team

- Subjects with the following laboratory values, unless approved by hematologist:

- Platelet count <100,000/mL

- APTT >39 sec or PT >15 sec

- Pregnancy or lactation

- Patient is unable to comply with requirements of the procedure, i.e. holding breath

- Participation in an investigational trial within 30 days of enrollment

- Any form of substance abuse (including drug or alcohol abuse), psychiatric disorder, or any chronic condition that could, in the opinion of the investigator, of interfering with the conduct of the study.

- Subjects who are uncooperative or cannot follow instructions

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Biopsy needle guidance system (ActiSight™)
The ActiSight system assists in guiding an aspiration or biopsy needle, to a designated point within the body by means of CT visualization.

Locations

Country Name City State
Israel Tel Aviv Sourasky Medical Center Tel Aviv

Sponsors (1)

Lead Sponsor Collaborator
ActiViews Ltd.

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of target reached within a radius of 8 mm from the preplanned targeted point as measured on the final CT scan. Measure evaluated during entire course of study No
Secondary Number of needle punctures through the skin Measure evaluated during entire course of study No
Secondary Number of needle punctures through the pleura Measure evaluated during entire course of study No
Secondary Number of CT scans needed Measure evaluated during entire course of study No
Secondary Radial distance at target plane at the needle's final position as shown on the ActiSight screen Measure evaluated during entire course of study No
Secondary Adverse events following the procedure, including the following:Pneumothorax, Hemoptysis >100 ml, Bleeding, Collapsed lung, Chest drainage, Need for hospitalization Measure evaluated during entire course of study Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04519554 - Hysteroscopic Guided Endometrial Sampling: Prospective Comparison Between 5Fr and 7Fr Biopsy Forceps (HYSTEROBIO) N/A
Not yet recruiting NCT02930616 - A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized,Cross-over Study Phase 4
Completed NCT00828893 - Navigation Guidance Gestures Carried Out Under CT Phase 2/Phase 3
Recruiting NCT04553601 - Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer N/A
Recruiting NCT04809025 - Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
Completed NCT01506778 - Tenaculum in Endometrial Sampling Procedure N/A
Active, not recruiting NCT04887597 - EBIO - Enthesitis Biopsy Study Phase 4
Completed NCT05012527 - Retrospective Review of Gastrointestinal System Endoscopy Procedures
Completed NCT06454513 - Efficacy of Different Anesthesia Methods in Transbronchial Biopsy
Withdrawn NCT02851693 - Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection N/A
Completed NCT01110148 - Use of Portable Technology in Patient Education of Shave/Punch Biopsies N/A
Completed NCT01212718 - Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase Phase 2
Completed NCT00819533 - Safety & Accuracy Study of the ActiSight Needle Guidance System in Patients Undergoing CT-Guided Percutaneous Chest Aspiration and Biopsy N/A
Recruiting NCT00635310 - Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin N/A
Completed NCT02756975 - Prostate Core Needle Biopsy N/A
Completed NCT01896219 - CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System N/A
Completed NCT03859804 - Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy N/A
Completed NCT01280435 - Islide-Establishing a Clinical Dermatopathology Online Discourse System N/A
Completed NCT00474968 - Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique. N/A